Atlas Trials

Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder

Clinical trial NCT01658150 · COMPLETED

Trial details

NCT number
NCT01658150
Sponsor
Icahn School of Medicine at Mount Sinai
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorder
Start date
2012-09-01
Primary completion
2018-01-02
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.